Barbaliscia, S. (2019). Characteristics and prevalence of HCV NS3, NS5A and NS5B resistance associated substitutions in HCV infected patients naive and treated with direct acting antivirals in Italy [10.58015/barbaliscia-silvia_phd2019].
Characteristics and prevalence of HCV NS3, NS5A and NS5B resistance associated substitutions in HCV infected patients naive and treated with direct acting antivirals in Italy
BARBALISCIA, SILVIA
2019-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi_220219_barbaliscia.pdf
non disponibili
Licenza:
Copyright degli autori
Dimensione
3.18 MB
Formato
Adobe PDF
|
3.18 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
